These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1529 related items for PubMed ID: 15062889

  • 1. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB, Lacourciere Y, Davidai G.
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [Abstract] [Full Text] [Related]

  • 2. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
    White WB, Davidai G, Schumacher H.
    J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
    [Abstract] [Full Text] [Related]

  • 3. Sustained antihypertensive activity of telmisartan compared with valsartan.
    Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H.
    Blood Press Monit; 2004 Aug; 9(4):203-10. PubMed ID: 15311147
    [Abstract] [Full Text] [Related]

  • 4. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
    White WB, Murwin D, Chrysant SG, Koval SE, Davidai G, Guthrie R.
    Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
    [Abstract] [Full Text] [Related]

  • 5. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T, Mroczek W, Marbury T, VanderMaelen CP, Dubiel RF.
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y, Neutel JM, Davidai G, Koval S.
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H, Akasaka H, Saitoh S, Shimamoto K, Miura T, SPEED investigators.
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [Abstract] [Full Text] [Related]

  • 8. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR.
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.
    Williams B, Lacourcière Y, Schumacher H, Gosse P, Neutel JM.
    J Hum Hypertens; 2009 Sep; 23(9):610-9. PubMed ID: 19225530
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 12. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 13. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH, Matzek KM, Kempthorne-Rawson J.
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T, Hashimoto J, Ohkubo T, Kikuya M, Metoki H, Asayama K, Totsune K, Imai Y.
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [Abstract] [Full Text] [Related]

  • 15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with stage 2 hypertension.
    Flack JM, Yadao AM, Purkayastha D, Samuel R, White WB.
    J Am Soc Hypertens; 2012 Sep; 6(2):142-51. PubMed ID: 22321963
    [Abstract] [Full Text] [Related]

  • 17. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.
    Palatini P, Jung W, Shlyakhto E, Botha J, Bush C, Keefe DL.
    J Hum Hypertens; 2010 Feb; 24(2):93-103. PubMed ID: 19458624
    [Abstract] [Full Text] [Related]

  • 20. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR.
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.